Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Novel and functional norepinephrine transporter protein variants identified in attention-deficit hyperactivity disorder.

Hahn MK, Steele A, Couch RS, Stein MA, Krueger JJ.

Neuropharmacology. 2009 Dec;57(7-8):694-701. doi: 10.1016/j.neuropharm.2009.08.002. Epub 2009 Aug 19.

2.

A haplotype of the norepinephrine transporter (Net) gene Slc6a2 is associated with clinical response to atomoxetine in attention-deficit hyperactivity disorder (ADHD).

Ramoz N, Boni C, Downing AM, Close SL, Peters SL, Prokop AM, Allen AJ, Hamon M, Purper-Ouakil D, Gorwood P.

Neuropsychopharmacology. 2009 Aug;34(9):2135-42. doi: 10.1038/npp.2009.39. Epub 2009 Apr 22.

3.

No evidence for association between a functional promoter variant of the Norepinephrine Transporter gene SLC6A2 and ADHD in a family-based sample.

Renner TJ, Nguyen TT, Romanos M, Walitza S, Röser C, Reif A, Schäfer H, Warnke A, Gerlach M, Lesch KP.

Atten Defic Hyperact Disord. 2011 Sep;3(3):285-9. doi: 10.1007/s12402-011-0060-4. Epub 2011 Jul 8.

PMID:
21739117
4.

A haplotype of the norepinephrine transporter gene (SLC6A2) is associated with visual memory in attention-deficit/hyperactivity disorder.

Shang CY, Chiang HL, Gau SS.

Prog Neuropsychopharmacol Biol Psychiatry. 2015 Apr 3;58:89-96. doi: 10.1016/j.pnpbp.2014.12.010. Epub 2014 Dec 30.

PMID:
25554436
5.

Functional gene variation in the human norepinephrine transporter: association with attention deficit hyperactivity disorder.

Kim CH, Waldman ID, Blakely RD, Kim KS.

Ann N Y Acad Sci. 2008;1129:256-60. doi: 10.1196/annals.1417.023. Review.

PMID:
18591486
6.

Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PET.

Sigurdardottir HL, Kranz GS, Rami-Mark C, James GM, Vanicek T, Gryglewski G, Kautzky A, Hienert M, Traub-Weidinger T, Mitterhauser M, Wadsak W, Hacker M, Rujescu D, Kasper S, Lanzenberger R.

Hum Brain Mapp. 2016 Mar;37(3):884-95. doi: 10.1002/hbm.23071. Epub 2015 Dec 17.

7.

Further evidence of association between two NET single-nucleotide polymorphisms with ADHD.

Kim JW, Biederman J, McGrath CL, Doyle AE, Mick E, Fagerness J, Purcell S, Smoller JW, Sklar P, Faraone SV.

Mol Psychiatry. 2008 Jun;13(6):624-30. Epub 2007 Sep 18.

PMID:
17876324
8.

Norepinephrine transporter and catecholamine-O-methyltransferase gene variants and attention-deficit/hyperactivity disorder symptoms in adults.

Retz W, Rösler M, Kissling C, Wiemann S, Hünnerkopf R, Coogan A, Thome J, Freitag C.

J Neural Transm (Vienna). 2008;115(2):323-9. Epub 2007 Nov 12.

PMID:
17994190
9.

Norepinephrine genes predict response time variability and methylphenidate-induced changes in neuropsychological function in attention deficit hyperactivity disorder.

Kim BN, Kim JW, Cummins TD, Bellgrove MA, Hawi Z, Hong SB, Yang YH, Kim HJ, Shin MS, Cho SC, Kim JH, Son JW, Shin YM, Chung US, Han DH.

J Clin Psychopharmacol. 2013 Jun;33(3):356-62. doi: 10.1097/JCP.0b013e31828f9fc3.

PMID:
23609393
10.

Possible association of norepinephrine transporter -3081(A/T) polymorphism with methylphenidate response in attention deficit hyperactivity disorder.

Kim BN, Kim JW, Hong SB, Cho SC, Shin MS, Yoo HJ.

Behav Brain Funct. 2010 Oct 7;6:57. doi: 10.1186/1744-9081-6-57.

11.

Association of norepinephrine transporter (NET, SLC6A2) genotype with ADHD-related phenotypes: findings of a longitudinal study from birth to adolescence.

Hohmann S, Hohm E, Treutlein J, Blomeyer D, Jennen-Steinmetz C, Schmidt MH, Esser G, Banaschewski T, Brandeis D, Laucht M.

Psychiatry Res. 2015 Apr 30;226(2-3):425-33. doi: 10.1016/j.psychres.2014.12.029. Epub 2014 Dec 27.

PMID:
25724484
12.

Norepinephrine transporter polymorphisms in Tourette syndrome with and without attention deficit hyperactivity disorder: no evidence for significant association.

Rippel CA, Kobets AJ, Yoon DY, Williams PN, Shugart YY, Bridges DD, Vandenbergh DJ, Singer HS.

Psychiatr Genet. 2006 Oct;16(5):179-80.

PMID:
16969268
13.

Comprehensive phenotype/genotype analyses of the norepinephrine transporter gene (SLC6A2) in ADHD: relation to maternal smoking during pregnancy.

Thakur GA, Sengupta SM, Grizenko N, Choudhry Z, Joober R.

PLoS One. 2012;7(11):e49616. doi: 10.1371/journal.pone.0049616. Epub 2012 Nov 20.

14.

Differential association between the norepinephrine transporter gene and ADHD: role of sex and subtype.

Sengupta SM, Grizenko N, Thakur GA, Bellingham J, DeGuzman R, Robinson S, TerStepanian M, Poloskia A, Shaheen SM, Fortier ME, Choudhry Z, Joober R.

J Psychiatry Neurosci. 2012 Feb;37(2):129-37. doi: 10.1503/jpn.110073.

15.

Norepinephrine transporter gene (SLC6A2) is involved with methylphenidate response in Korean children with attention deficit hyperactivity disorder.

Song J, Song DH, Jhung K, Cheon KA.

Int Clin Psychopharmacol. 2011 Mar;26(2):107-13. doi: 10.1097/YIC.0b013e32834152d1.

PMID:
21127421
16.
17.

Attention deficit hyperactivity disorder: genetic association study in a cohort of Spanish children.

Gomez-Sanchez CI, Riveiro-Alvarez R, Soto-Insuga V, Rodrigo M, Tirado-Requero P, Mahillo-Fernandez I, Abad-Santos F, Carballo JJ, Dal-Ré R, Ayuso C.

Behav Brain Funct. 2016 Jan 8;12(1):2. doi: 10.1186/s12993-015-0084-6.

18.

Possible effect of norepinephrine transporter polymorphisms on methylphenidate-induced changes in neuropsychological function in attention-deficit hyperactivity disorder.

Park S, Kim JW, Yang YH, Hong SB, Park MH, Kim BN, Shin MS, Yoo HJ, Cho SC.

Behav Brain Funct. 2012 May 16;8:22. doi: 10.1186/1744-9081-8-22.

19.

The dopamine transporter and attention-deficit/hyperactivity disorder.

Madras BK, Miller GM, Fischman AJ.

Biol Psychiatry. 2005 Jun 1;57(11):1397-409. Epub 2005 Jan 5. Review.

PMID:
15950014
20.

The possible involvement of genetic variants of NET1 in the etiology of attention-deficit/hyperactivity disorder comorbid with oppositional defiant disorder.

Liu L, Cheng J, Li H, Yang L, Qian Q, Wang Y.

J Child Psychol Psychiatry. 2015 Jan;56(1):58-66. doi: 10.1111/jcpp.12278. Epub 2014 Jun 19.

PMID:
24942521

Supplemental Content

Support Center